Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Organogenesis (ORGO) has a market cap of $0.55 billion USD. According to our data, Organogenesis is ranked No.5855 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.55 B |
36.18%
|
| Dec 31, 2024 | $0.40 B |
-21.76%
|
| Dec 29, 2023 | $0.51 B |
52.04%
|
| Dec 30, 2022 | $0.34 B |
-70.89%
|
| Dec 31, 2021 | $1.16 B |
22.71%
|
| Dec 31, 2020 | $0.95 B |
56.55%
|
| Dec 31, 2019 | $0.60 B |
-52.61%
|
| Dec 31, 2018 | $1.28 B |
2.32%
|
| Dec 29, 2017 | $1.25 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Integra LifeSciences
IART
|
$1.24 B |
-0.000 M
|
USA
|
 MiMedx Group
MDXG
|
$1.00 B |
0.000 M
|
USA
|
 Vericel
VCEL
|
$2.11 B |
-0.000 M
|
USA
|
 Smith & Nephew
SNN
|
$11.39 B |
0.000 M
|
UK
|
 Stryker Corporation
SYK
|
$132.37 B |
-0.002 M
|
USA
|
 Zimmer Biomet
ZBH
|
$19.24 B |
0.000 M
|
USA
|
 Medtronic
MDT
|
$105.64 B |
0.002 M
|
Ireland
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Baxter
BAX
|
$14.26 B |
0.000 M
|
USA
|
 Boston Scientific
BSX
|
$139.37 B |
0.007 M
|
USA
|
 Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
USA
|
 Edwards Lifesciences
EW
|
$41.45 B |
0.000 M
|
USA
|
| Market Cap | = | ORGO Stock Price | * | ORGO Shares Outstanding |
| = | $4.32 | * | 0.13 B | |
| = | $0.55 B |